Evaluation of flow cytometric panel reactive antibody in renal transplant recipients - Examination of 238 cases of renal transplantation

Transplant International

Volumn 18, Issue 2, 2005, Pages 163-168

  Ishida, Hideki ^a   Tanabe, Kazunari ^a   Furusawa, Miyuki ^a   Ishizuka, Tsutomu ^a   Hayashi, Tetsuo ^a   Tokumoto, Tadahiko ^a   Miyamoto, Naoshi ^a   Shirakawa, Hiroki ^a   Shimimura, Hiroaki ^a   Shimizu, Tomokazu ^a   Toma, Hiroshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Flow cytometry; Panel reactive antibody; Renal transplantation

Indexed keywords

ANTIBODY; AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN A; MIZORIBINE; STEROID; ALLOANTIBODY; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOSUPPRESSIVE AGENT;

ANTIGEN ANTIBODY REACTION; ARTICLE; BIOPSY; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CYTOTOXICITY TEST; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TECHNIQUE; ADULT; BLOOD; BLOOD GROUP ABO SYSTEM; CHILD; COMPARATIVE STUDY; DONOR; EVALUATION; HISTOCOMPATIBILITY TEST; IMMUNOASSAY; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY;

ABO BLOOD-GROUP SYSTEM; ADULT; CHILD; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOASSAY; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 20444437616     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2004.00048.x     Document Type: Article

References (14)

1. Tanabe K, Takahashi K, Sonda K, et al. Long term results of ABO incompatible living renal transplantation. Transplantation 1998; 65: 224.
2. Bjorkman PJ, Saper MA, Samraoni B. Structure of the human class 1 histocompatibility antigen HLA-A2. Nature 1987; 329: 506.
3. Dress M, Cosman D, Khonry G. Secretion of a transplanted antigen. Cell 1983; 34: 189.
4. Cecka JM, Terasaki PI. The UNOS scientific Renal Transplant Registry. 1991. Clin Transplant 1991; 1: 18.
5. Terasaki PI, Cecka JM, Takemoto S, et al. Clinical transplantation 1998. Overview. Clin Transplant 1991; 409: 4.
6. Pei R, Wang G, Tarcitani C. Simultaneous HLA class 1 and class 2 antibodies screening with flow cytometry. Hum Immunol 1998; 5: 313.
7. Mahanty HD, Cherikh WS, Chang GJ. Influence of pretransplant pregnancy on survival of renal allograft from living donors. Transplantation 2001; 72: 228.
8. Ishida H, Tanabe K, Tokumoto T. The evaluation of graft irradiation as a method of preventing hemolysis after ABO mismatched renal transplantations. Transplant Int 2002; 15: 421.
9. Garovoy MR, Rheinschmilt MA, Bigos M. Flow cytometry analysis: a high technology crossmatch technique facilitating transplantation. Transplant Proc 1983; 15: 1939.
10. Kahan BD, United States Simulect Renal Study Group. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with Basiliximab. Transplantation 1999; 67: 276.
11. Halloran PF, Schlaut J, Solez K, Srinvasa NS. The significance of the anti-class 1 response. Clinical and pathologic features of renal transplants with anti-class1-like antibody. Transplantation 1992; 53: 550.
12. Reinsmoen N, Kaestner S, Harland R. Increased risk of acute and chronic rejection in sensitized kidney recipients with HLA class2 directed donor antigen-specific antibodies. In: Tearasaki P, ed. Visuals of the Clinical Histocompatibility Workshop: Palm Springs Invitational. Palm Springs, CA: One Lamda Inc., 1999: p. 12.
13. Buelow R, Mercier I, Glanville L. Detection of panel reactive anti-HLA antibodies by PRA-STAT ELISA or lymphocytotoxicity; result of a blinded, controlled multicenter study. Hum Immunol 1995; 44: 1.
14. Kerman RH, Susskind B, Kahan BD. Correlation of ELISA-detected IgG and IgA anti-HLA antibodies in pretransplant sera with allograft rejection. Transplantation 1996; 62: 201.